The European Hematology Curriculum: An Electronic Passport Promoting Professional Competence and Mobility

por Almeida, A.M., Ar, C., Hellström-Lindberg, E., Hollegien, W.W.G., Navarro, J.T., Saris, M.T., Wondergem, M.J., Toh, C.H.
Publicado 2018

(18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma

por Regelink, J. C., Raijmakers, P. G., Bravenboer, N., Milek, R., Hoetjes, N. J., de Kreuk, A. M., van Duin, M., Wondergem, M. J., Lips, P., Sonneveld, P., Zijlstra, J. M., Zweegman, S.
Publicado 2016

P1209: INCIDENCE, TREATMENT AND OUTCOME OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: A POPULATION-BASED COHORT STUDY IN THE NETHERLANDS

por Meeuwes, F. O., Brink, M., Van der Poel, M. W., Kersten, M. J., Wondergem, M. J., Mutsaers, P. G., Böhmer, L. H., Woei-A-Jin, F. J. S. H., Visser, O., Oostvogels, R., Jansen, P. M., Plattel, W. J., Huls, G. A., Vermaat, J. S., Nijland, M.
Publicado 2022

P1030: MANIFEST-2, A GLOBAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL STUDY OF PELABRESIB (CPI-0610) AND RUXOLITINIB VS PLACEBO AND RUXOLITINIB IN JAK INHIBITOR-NAÏVE MYEL...

por Harrison, C., Rampal, R. K., Gupta, V., Verstovsek, S., Talpaz, M., Kiladjian, J.-J., Mesa, R., Kuykendall, A., Vannucchi, A., Palandri, F., Grosicki, S., Devos, T., Jourdan, E., Wondergem, M. J., Al-Ali, H. K., Buxhofer-Ausch, V., Alvarez-Larrán, A., Akhani, S., Muñoz-Carerras, R., Sheykin, Y., Colak, G., Harris, M., Mascarenhas, J.
Publicado 2022